Chemdiv : Main Page 
 
Online Ordering  
 
  
Company

Scientific advisory
board


Alexander Ivachtchenko, Prof., DSc.
Founder of ChemDiv, Chief Scientific Officer, Founding Memeber of Scientific Advisory Board

Professor Ivachtchenko is the founder of ChemDiv, Chief Scientific Officer and the founding member of the Scientific Advisory Board. He is the recipient of multiple European awards in the field of heterocyclic chemistry and has earned the prestigious title of Honored Inventor of the Russian Federation. Professor Ivachtchenko has a PhD in Chemistry from the Institute of Chemical Industry, a DSc in Chemistry from Mendeleev University of Chemical Technology. He is the author of 4 text books, 173 scientific papers and 141 patent applications.

Hugo Kubinyi, Prof, DSc.
University of Heidelberg

Professor Kubinyi is a member of the SAB of ChemDiv and currently the Professor of Pharmaceutical Chemistry at the University of Heidelberg. He has previously held the Chair of The QSAR and Modeling Society was an IUPAC Fellow and has been a prominent member of the QSAR and Molecular Modeling Society for 40 years. For 35 years he was responsible for the Molecular Modeling, X-ray Crystallography and Drug Design groups at BASF Pharmaceuticals. Professor Kubinyi has a PhD in Biochemistry from the Max Planck Institute and is the author of 5 text books, 90 scientific papers.

Tudor Oprea, Prof, PhD, MD.
University of New Mexico

Professor Oprea is a member of the SAB of ChemDiv and is currently Professor and Chief of the Division of Bio-computing at the University of New Mexico, School of Medicine in Albuquerque. Previously he was founder of Sunset Molecular Discovery LLC (SMDL), spent six years with AstraZeneca in Sweden and completed a successful academic tenure at the West University of Timisoara, Romania (1996-2003). Professor Oprea has an MD in general medicine and a PhD in molecular physiology from the "Victor Babes" University of Medicine and Pharmacy in Timisoara, Romania. He is the author or co-author of 13 book chapters, 43 scientific papers and 1 patent application.

Y.Yamomoto, Prof, DSc.
Tohoku University

Professor Yamomoto is a member of the SAB of ChemDiv. His major research interests include the development of new synthetic reactions using organometallic reagents and catalysts, natural product synthesis and medicinal chemistry, and asymmetric & stereoselective syntheses. Professor Yamomoto is the recipient of the Chemical Society of Japan Award (1996), and the Humboldt Research Award (2002).

 
 
Search
 
NEWS
ChemDiv and Avineuro extend Alzheimer’s and Schizophrenia collaboratio ...
November 15, 2008
Oncalis AG licenses PI3K inhibitors from ChemDiv, Inc.
October 6, 2008
 
All news
 
NEW PRODUCTS AND SERVICES
Preclinical Profiling
High throughput hit hunting
Biologically Annotated Libraries
Focused Diversity
 
More...
  
 Discovery outSourceSynthetic chemistryMedicinal chemistryScreening librariesGlobal logisticsPreclinical development